Cystic Fibrosis Foundation Therapeutics, Inc., the CF Foundation???s nonprofit drug discovery and development affiliate, is the primary source of funding for the TDN. Additional funding for some clinical studies comes from pharmaceutical companies or government agencies such as the National Institutes of Health and U.S. Food and Drug Administration.